Copyright
©2010 Baishideng.
World J Gastroenterol. Jun 21, 2010; 16(23): 2873-2880
Published online Jun 21, 2010. doi: 10.3748/wjg.v16.i23.2873
Published online Jun 21, 2010. doi: 10.3748/wjg.v16.i23.2873
Figure 4 Effects of CXCR4 antagonist on migration and cytokine production of isolated PBMCs.
To mimic the in vivo inflammatory response, the PBMCs were pre-activated with PHA. Migration of PBMCs (A) and levels of TNF-α (B), IL-6 (C), and IFN-γ ( D) in PBMCs are shown. Six wells were studied in each experimental group. Results are mean ± SE. aP < 0.05, chemokine stromal cell-derived factor-1 (CXCL12) group vs control group; cP < 0.05, AMD3100 group vs CXCL12 group.
- Citation: Xia XM, Wang FY, Xu WA, Wang ZK, Liu J, Lu YK, Jin XX, Lu H, Shen YZ. CXCR4 antagonist AMD3100 attenuates colonic damage in mice with experimental colitis. World J Gastroenterol 2010; 16(23): 2873-2880
- URL: https://www.wjgnet.com/1007-9327/full/v16/i23/2873.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i23.2873